Current practices of donor pancreas allocation in the UK: Future implications for pancreas and islet transplantation

Transplant International

Volumn 18, Issue 7, 2005, Pages 828-834

  Ridgway, Dan M ^a,b   White, Steven A ^a   Kimber, Rachel M ^a   Nicholson, Michael L ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b Northern Lincolnshire and Goole Hospitals NHS Foundation Trust   (United Kingdom)

Author keywords

Islet transplantation; Organ donation; Pancreas transplantation

Indexed keywords

CLINICAL PRACTICE; CONFERENCE PAPER; DIABETES MELLITUS; HUMAN; ORGAN DONOR; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; UNITED KINGDOM; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DONOR; HEALTH CARE ORGANIZATION; HEALTH PERSONNEL ATTITUDE; INFANT; INFORMED CONSENT; METHODOLOGY; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; QUESTIONNAIRE; STATISTICS; TIME; TRANSPLANTATION;

ADOLESCENT; ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; CHILD; CHILD, PRESCHOOL; GREAT BRITAIN; HEALTH CARE RATIONING; HUMANS; INFANT; INFANT, NEWBORN; INFORMED CONSENT; ISLETS OF LANGERHANS TRANSPLANTATION; MIDDLE AGED; PANCREAS TRANSPLANTATION; QUESTIONNAIRES; TIME FACTORS; TISSUE AND ORGAN HARVESTING; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 26044457942     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2005.00144.x     Document Type: Conference Paper

References (32)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977.
2. Sutherland DE, Gruessner RW, Dunn DL, et al. Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg 2001; 233: 463.
3. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998; 339: 69.
4. Navarro X, Sutherland DE, Kennedy WR. Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol 1997; 42: 727.
5. Tyden G, Bounder J, Solders G, Brattstrom C, Tibell A, Groth CG. Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation. Transplantation 1999; 67: 645.
6. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230.
7. Shapiro AMJ, Hering B, Ricordi C, et al. International multi-center trial of islet transplantation using the Edmonton protocol in patients with type 1 diabetes. Am J Transplant 2003; 3(Suppl. 5): 152.
8. Hering B, Harmon J, Ansite JD, et al. Successful single donor islet transplantation in type 1 diabetes with hOKT3g-1 (ala-ala), sirolimus and tacrolimus therapy. Acta Chir Austriaca 2001; 33(Suppl): 33.
9. Krieger NR, Odorico JS, Heisey DM, et al. Under-utilization of pancreas donors. Transplantation 2003; 75: 1271.
10. Kapur S, Bonham CA, Dodson SF, Dvorchik I, Corry RJ. Strategies to expand the donor pool for pancreas transplantation. Transplantation 1999; 67: 284.
11. UK Transplant Statistics. [Accessed Nov 2004] www.uktransplant.org.uk/ ukt/statistics/
12. Ris F, Toso C, Veith FU, Majno P, Morel P, Oberholzer J. Are criteria for islet and pancreas donors sufficiently different to minimize competition? Am J Transplant 2004; 4: 763.
13. Lakey JR, Warnock GL, Rajotte RV, et al. Factors in cadaveric donors that affect recovery of human islets of Langerhans. Transplant Proc 1995; 27: 3265.
14. Benhamou PY, Watt PC, Mullen Y, et al. Human islet isolation in 104 consecutive cases. Factors affecting isolation success. Transplantation 1994; 57: 1804.
15. Tan M, Kandaswamy R, Sutherland DE, Gruessner RW, Gruessner AC, Humar A. Risk factors and impact of delayed graft function after pancreas transplants. Am J Transplant 2004; 4: 758.
16. Douzdjian V, Gugliuzza KG, Fish JC. Multivariate analysis of donor risk factors for pancreas allograft failure after simultaneous pancreas-kidney transplantation. Surgery 1995; 118: 73.
17. Gores PF, Gillingham KJ, Dunn DL, Moudry-Munns KC, Najarian JS, Sutherland DE. Donor hyperglycemia as a minor risk factor and immunologic variables as major risk factors for pancreas allograft loss in a multivariate analysis of a single institution's experience. Ann Surg 1992; 215: 217.
18. Knight RJ, Bodian C, Rodriguez-Laiz G, Guy SR, Fishbein TM. Risk factors for intra-abdominal infection after pancreas transplantation. Am J Surg 2000; 179: 99.
19. Lakey JR, Kneteman NM, Rajotte RV, Wu DC, Bigam D, Shapiro AM. Effect of core pancreas temperature during cadaveric procurement on human islet isolation and functional viability. Transplantation 2002; 73: 1106.
20. Wigmore SJ, Seeney FM, Pleass HC, Praseedom RK, Forsythe JL. Kidney damage during organ retrieval: data from UK National Transplant Database. Kidney Advisory Group. Lancet 1999; 354: 1143.
21. Kneteman N, Lake JR, Warnock GL, Rajotte R. Human islet isolation after prolonged cold storage. Diabetes Nutr Metab 1992; 5: 33.
22. Lakey JR, Rajotte RV, Warnock GL, Kneteman NM. Human pancreas preservation prior to islet isolation. Cold ischemic tolerance. Transplantation 1995; 59: 689.
23. Kuroda Y, Morita A, Fujino Y, Tanioka Y, Ku Y, Saitoh Y. Successful extended preservation of ischemically damaged pancreas by the two-layer (University of Wisconsin solution/perfluorochemical) cold storage method. Transplantation 1993; 56: 1087.
24. Lakey JR, Tsujimura T, Shapiro AM, Kuroda Y. Preservation of the human pancreas before islet isolation using a two-layer (UW solution- perfluorochemical) cold storage method. Transplantation 2002; 74: 1809.
25. Ricordi C, Fraker C, Szust J, et al. Improved human islet isolation outcome from marginal donors following addition of oxygenated perfluorocarbon to the cold-storage solution. Transplantation 2003; 75: 1524.
26. Tsujimura T, Kuroda Y, Avila JG, et al. Influence of pancreas preservation on human islet isolation outcomes: impact of the two-layer method. Transplantation 2004; 78: 96.
27. Yong BH, Cheng B, Ho S. Refusal of consent for organ donation: from survey to bedside. Transplant Proc 2000; 32: 1563.
28. Siminoff LA, Gordon N, Hewlett J, Arnold RM. Factors influencing families' consent for donation of solid organs for transplantation. JAMA 2001; 286: 71.
29. Wight C, Cohen B. Organ shortages: maximising the donor potential. Br Med Bull 1997; 53: 817.
30. Wight C, Cohen B. What is the Eurotransplant Foundation doing about the organ shortage? Transplant Proc 1997; 29: 3208.
31. Kessler L, Bucher P, Milliat-Guittard L, Benhamou PY, Berney T, Penfornis A, et al. Influence of islet transportation on pancreatic islet allotransplantation in type 1 diabetic patients within the Swiss-French GRAGIL network. Transplantation 2004; 77: 1301.
32. Steering Committee on Bioethics (CDBI). Draft protocol on transplantation of organs and tissues of human origin. J Int Bioethique 2001; 12: 47.